Home Stock

Stock Research: Integral Diagnostics

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Integral Diagnostics

ASX:IDX AU000000IDX2
66
  • Value
    72
  • Growth
    47
  • Safety
    Safety
    8
  • Combined
    31
  • Sentiment
    100
  • 360° View
    360° View
    66
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Integral Diagnostics Limited is an Australia-based provider of medical imaging services. It operates in diagnostic imaging services through brands like Lake Imaging, The X-Ray Group, South Coast Radiology, Peloton Radiology, Imaging Queensland, Apex Radiology, Astra Radiology, SRG Radiology, Horizon Radiology, and Trinity MRI. The company operates across four Australian States: Victoria, New South Wales, Queensland, and Western Australia, and also in New Zealand. In the last fiscal year, the company had 1977 employees, a market cap of $645 million, profits of $298 million, and revenue of $313 million.

more

ANALYSIS: With an Obermatt 360° View of 66 (better than 66% compared with alternatives), overall professional sentiment and financial characteristics for the stock Integral Diagnostics are above average. The 360° View is based on consolidating four consolidated indicators, with half the metrics below and half above average for Integral Diagnostics. The consolidated Value Rank has an attractive rank of 72, which means that the share price of Integral Diagnostics is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means that the stock price is lower than for 72% of alternative stocks in the same industry. The consolidated Sentiment Rank has a good rank of 100, which means that professional investors are more optimistic about the stock than for 100% of alternative investment opportunities. But the consolidated Growth Rank has a low rank of 47, which means that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, invested capital growth, and stock returns. The consolidated Safety Rank has a riskier rank of 8, meaning the company has a riskier financing structure than 92 comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. ...read more

more
Strongest Rank Safety
Weakest Rank Sentiment
Country Australia
Industry Health Care Services
Size Medium
Website integraldiagnostics.com.au
Index
ASX 300
Integral Diagnostics stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 13-Mar-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
72 57 91 55
Growth
47 100 29 45
Safety
Safety
8 6 10 6
Sentiment
100 69 34 80
360° View
360° View
66 71 17 33
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
78 89 69 73
Opinions Change
50 47 44 50
Pro Holdings
n/a 53 53 70
Market Pulse
84 42 13 52
Sentiment
100 69 34 80
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
72 57 91 55
Growth
47 100 29 45
Safety Safety
8 6 10 6
Combined
31 50 23 10
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
65 63 79 57
Price vs. Earnings (P/E)
52 44 54 47
Price vs. Book (P/B)
58 40 71 45
Dividend Yield
91 78 86 68
Value
72 57 91 55
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
88 92 47 65
Profit Growth
33 96 45 23
Capital Growth
25 89 60 34
Stock Returns
57 87 7 67
Growth
47 100 29 45
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
12 9 10 4
Refinancing
16 12 10 14
Liquidity
24 16 20 19
Safety Safety
8 6 10 6

Similar Stocks

Discover high‑ranked alternatives to Integral Diagnostics and broaden your portfolio horizons.

Shionogi

TYO:4507
Country: Japan
Industry: Pharmaceuticals
Size: X-Large
Full Stock Analysis

Alfresa Holdings

TYO:2784
Country: Japan
Industry: Health Care Distributors
Size: X-Large
Full Stock Analysis

Kyowa Hakko Kirin

TYO:4151
Country: Japan
Industry: Pharmaceuticals
Size: X-Large
Full Stock Analysis

Astellas Pharma

TYO:4503
Country: Japan
Industry: Pharmaceuticals
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

With good value and positive sentiment, but low growth and risky financing, this combination is generally dangerous as debt requires growth to sustain it. Only investors with a strong belief in future growth potential and a high-risk tolerance should consider this stock.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews